Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)

PHASE4TerminatedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Intraocular Pressure
Interventions
DRUG

Travoprost 0.004% + Brinzolamide 1.0%

Travoprost 0.004% (once daily) + Brinzolamide 1.0% (twice daily)

DRUG

Travoprost 0.004% + Tears Natural

Travoprost 0.004% (once daily) + Tears Naturale (twice daily)

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY